Exact Mass: 528.1717

Exact Mass Matches: 528.1717

Found 131 metabolites which its exact mass value is equals to given mass value 528.1717, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tremulacin

[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[2-[(1-hydroxy-6-oxo-cyclohex-2-ene-1-carbonyl)oxymethyl]phenoxy]tetrahydropyran-3-yl] benzoate

C27H28O11 (528.1632)

Tremulacin is a glycoside. Tremulacin is a natural product found in Populus tremula, Populus tomentosa, and other organisms with data available.

17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide)

(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-{[(1S,10R,11S,14S,15S)-15-methyl-5-(sulfooxy)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2(7),3,5-trien-14-yl]oxy}oxane-2-carboxylic acid

C24H32O11S (528.1665)

17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide) is a natural human metabolite of 17beta-estradiol 3-sulfate generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. 17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide) is a natural human metabolite of 17beta-estradiol 3-sulfate generated in the liver by UDP glucuonyltransferase.

Estradiol 3-glucuronide 17beta-sulfate

17beta-Estradiol-3-(beta-D-glucuronide) 17-sulfate

C24H32O11S (528.1665)

Razaxaban

N-(4-{2-[(dimethylamino)methyl]-1H-imidazol-1-yl}-2-fluorophenyl)-1-(3-imino-2,3-dihydro-1,2-benzoxazol-5-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboximidic acid

C24H20F4N8O2 (528.1645)

Annotation level-3

7-oxo-3,8,9-trihydroxystaurosporine trifluoroacetate

C28H24N4O7 (528.1645)

Diacetylpratensin B

C27H28O11 (528.1632)

biselide A

C25H33ClO10 (528.1762)

(10S)-C-(5-O-acetyl-3-O-senecioyl)-beta-D-xylopyranosyl-1,8,10-trihydroxy-3-methyl-anthracen-9-one|alvaradoin J

C27H28O11 (528.1632)

cyathostemmine

C31H28O8 (528.1784)

C27H28O11

C27H28O11 (528.1632)

shikimic acid triphenylacetate

C31H28O8 (528.1784)

C26H28N2O10

C26H28N2O10 (528.1744)

(2S)-dihydrotricin 4-O-(erythro-beta-guaiacylglyceryl) ether|(2S)-dihydrotricin 4-O-(threo-beta-guaiacylglyceryl) ether|calquiquelignan A|calquiquelignan B

C27H28O11 (528.1632)

Curtisian S

C31H28O8 (528.1784)

Asp Glu His Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carboxybutanamido]-3-(1H-imidazol-4-yl)propanamido]pentanedioic acid

C20H28N6O11 (528.1816)

Cys Glu Phe Met

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Cys Glu Met Phe

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Cys Phe Glu Met

(4S)-4-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-4-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Cys Phe Met Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]pentanedioic acid

C22H32N4O7S2 (528.1712)

Cys Met Glu Phe

(4S)-4-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Cys Met Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]pentanedioic acid

C22H32N4O7S2 (528.1712)

Asp Glu Glu His

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carboxybutanamido]-4-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butanoic acid

C20H28N6O11 (528.1816)

Asp His Glu Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carboxybutanamido]pentanedioic acid

C20H28N6O11 (528.1816)

Glu Cys Phe Met

(4S)-4-amino-4-{[(1R)-1-{[(1S)-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-2-phenylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Glu Cys Met Phe

(4S)-4-amino-4-{[(1R)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Glu Asp Glu His

(4S)-4-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carboxypropanamido]-4-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butanoic acid

C20H28N6O11 (528.1816)

Glu Asp His Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]pentanedioic acid

C20H28N6O11 (528.1816)

Glu Glu Asp His

(4S)-4-[(2S)-2-amino-4-carboxybutanamido]-4-{[(1S)-2-carboxy-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C20H28N6O11 (528.1816)

Glu Glu His Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carboxybutanamido]-3-(1H-imidazol-4-yl)propanamido]butanedioic acid

C20H28N6O11 (528.1816)

Glu Phe Cys Met

(4S)-4-amino-4-{[(1S)-1-{[(1R)-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-2-sulfanylethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Glu Phe Met Cys

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Glu His Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carboxypropanamido]pentanedioic acid

C20H28N6O11 (528.1816)

Glu His Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carboxybutanamido]butanedioic acid

C20H28N6O11 (528.1816)

Glu Met Cys Phe

(4S)-4-amino-4-{[(1S)-1-{[(1R)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Glu Met Phe Cys

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-phenylethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Phe Cys Glu Met

(4S)-4-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-4-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Phe Cys Met Glu

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]pentanedioic acid

C22H32N4O7S2 (528.1712)

Phe Glu Cys Met

(4S)-4-[(2S)-2-amino-3-phenylpropanamido]-4-{[(1R)-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Phe Glu Met Cys

(4S)-4-[(2S)-2-amino-3-phenylpropanamido]-4-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Phe Met Cys Glu

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]pentanedioic acid

C22H32N4O7S2 (528.1712)

Phe Met Glu Cys

(4S)-4-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

His Asp Glu Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carboxypropanamido]-4-carboxybutanamido]pentanedioic acid

C20H28N6O11 (528.1816)

His Glu Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carboxybutanamido]-3-carboxypropanamido]pentanedioic acid

C20H28N6O11 (528.1816)

His Glu Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carboxybutanamido]-4-carboxybutanamido]butanedioic acid

C20H28N6O11 (528.1816)

Met Cys Glu Phe

(4S)-4-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Met Cys Phe Glu

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]pentanedioic acid

C22H32N4O7S2 (528.1712)

Met Glu Cys Phe

(4S)-4-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-{[(1R)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Met Glu Phe Cys

(4S)-4-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

Met Phe Cys Glu

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]pentanedioic acid

C22H32N4O7S2 (528.1712)

Met Phe Glu Cys

(4S)-4-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C22H32N4O7S2 (528.1712)

17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide)

C24H32O11S (528.1665)

benzene-1,3-diol,formaldehyde,3-phenylbenzene-1,2-diol,4-phenylbenzene-1,2,3-triol

C31H28O8 (528.1784)

zinc bis(dipentyldithiocarbamate)

C22H44N2S4Zn (528.1679)

Sofosbuvir impurity J

C22H30FN4O8P (528.1785)

L-Alanine, N-[(2R)-2-deoxy-2-fluoro-2-methyl-P-phenyl-5-cytidylyl]-,1-methylethyl ester

C22H30FN4O8P (528.1785)

Razaxaban

C24H20F4N8O2 (528.1645)

C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173067 - Direct Factor Xa Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant

[9-[2-Carboxy-4-(2,5-dioxopyrrolidin-1-yl)oxycarbonylphenyl]-6-(dimethylamino)xanthen-3-ylidene]-dimethylazanium

C29H26N3O7+ (528.1771)

7-Oxo-3,8,9-trihydroxy staurosporine

C28H24N4O7 (528.1645)

A indolocarbazole alkaloid that is staurosporine substituted by hydroxy groups at positions 3, 8 and 9 and an oxo group at position 7. Isolated from Cystodytes solitus, it exhibits cytotoxic activity.

Alvaradoin J

C27H28O11 (528.1632)

A C-glycosyl compound that is 1,8,10-trihydroxy-3-methylanthracen-9-one substituted by a 1-O-acetyl-3-O-senecioyl-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

Alvaradoin I

C27H28O11 (528.1632)

A C-glycosyl compound that is 1,8,10-trihydroxy-3-methylanthracen-9-one substituted by a 1-O-acetyl-3-O-senecioyl-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10R stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

alpha-Neup5Gc-(2->6)-D-GalpNAc

C19H32N2O15 (528.1803)

An amino disaccharide consisting of an N-glycoloylneuraminyl residue linked alpha(2->6) to an N-acetylglucosamine moiety.

alpha-Neup5Gc-(2->6)-alpha-D-GalpNAc

C19H32N2O15 (528.1803)

alpha-Neup5Gc-(2->6)-D-GalpNAc in which the anomeric configuration at the reducing end is alpha.

N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-2-sulfonamide

C27H32N2O5S2 (528.1753)

N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-2-sulfonamide

C27H32N2O5S2 (528.1753)

N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-3-sulfonamide

C27H32N2O5S2 (528.1753)

N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-2-sulfonamide

C27H32N2O5S2 (528.1753)

N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-3-sulfonamide

C27H32N2O5S2 (528.1753)

N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-3-sulfonamide

C27H32N2O5S2 (528.1753)

N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-2-sulfonamide

C27H32N2O5S2 (528.1753)

N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-3-sulfonamide

C27H32N2O5S2 (528.1753)

N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-2-sulfonamide

C27H32N2O5S2 (528.1753)

N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-3-sulfonamide

C27H32N2O5S2 (528.1753)

N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-2-sulfonamide

C27H32N2O5S2 (528.1753)

N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-2-sulfonamide

C27H32N2O5S2 (528.1753)

N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-2-sulfonamide

C27H32N2O5S2 (528.1753)

N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylthiophene-3-sulfonamide

C27H32N2O5S2 (528.1753)

17beta-Estradiol-3-(beta-D-glucuronide) 17-sulfate

C24H32O11S (528.1665)

3,5-dideoxy-5-glycolamido-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->6)-2-acetamido-2-deoxy-D-galacto-hexopyranose

C19H32N2O15 (528.1803)

NeuGc(a2-6)b-GalNAc

C19H32N2O15 (528.1803)

3,5-dideoxy-5-glycolamido-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->6)-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose

C19H32N2O15 (528.1803)

(2S,3R,4S,5R,6R)-3,5-dihydroxy-6-[[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]oxy]-4-sulfooxyoxane-2-carboxylic acid

C24H32O11S (528.1665)

(2S,3R,4S,5R,6S)-3,5-dihydroxy-6-[[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-sulfooxyoxane-2-carboxylic acid

C24H32O11S (528.1665)

2-(1-(2,4-Dinitrophenylhydrazonomethyl)ethyl)-5-methylcyclopentanecarbaldehyde 2,4-dinitrophenylhydrazone

C22H24N8O8 (528.1717)

Estradiol 17beta-glucuronide 3-sulfate

estra-1,3,5(10)-triene-3,17beta-diol 3-sulfate-17-D-glucuronide

C24H32O11S (528.1665)

ST 24:5;O8;S

C24H32O11S (528.1665)

LUT014

C27H19F3N8O (528.1634)

LUT014 is a B-Raf inhibitor with an IC50 of 11.7 nM, and developed to reduce dose-limiting acneiform lesions associated EGFR Inhibitors treatment. Extracted from patent WO 2019026065A2 [1].

Relenopride (hydrochloride)

C24H31Cl2FN4O4 (528.1706)

Relenopride (YKP10811) hydrochloride is a specific and selective 5-HT4 receptor agonist (Ki=4.96 nM). Relenopride hydrochloride has 120-fold and 6-fold lower affinity, respectively, for 5-HT2A (Ki=600 nM) and 5-HT2B receptors (Ki=31 nM) than for 5-HT4. Relenopride hydrochloride increases gastrointestinal (GI) motility[1][2].

(3r,4s,5r)-3,4,5-tris[(2-phenylacetyl)oxy]cyclohex-1-ene-1-carboxylic acid

C31H28O8 (528.1784)

(2s,3r,4s,5r,6r)-3,5-dihydroxy-2-(2-{[(1s)-1-hydroxy-6-oxocyclohex-2-ene-1-carbonyloxy]methyl}phenoxy)-6-(hydroxymethyl)oxan-4-yl benzoate

C27H28O11 (528.1632)

(3ar,4r,9r,9as)-9-(2h-1,3-benzodioxol-5-yl)-3a,9a-dihydroxy-6,7,8-trimethoxy-1-oxo-3h,4h,9h-naphtho[2,3-c]furan-4-yl (2e)-2-methylbut-2-enoate

C27H28O11 (528.1632)

(2r,3r,4r,5r,6s)-2-(acetyloxy)-3,5-dihydroxy-6-[(9s)-4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl]oxan-4-yl 3-methylbut-2-enoate

C27H28O11 (528.1632)

(6bs,10s,10as,11r)-10-(3,4-dihydroxyphenyl)-5-hydroxy-11-(4-hydroxy-2-methoxyphenyl)-6-methoxy-8-methyl-6bh,9h,10h,10ah,11h-indeno[2,1-f]chromen-3-one

C31H28O8 (528.1784)

11,12,18,23-tetrahydroxy-5-methoxy-6-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaen-16-one

11,12,18,23-tetrahydroxy-5-methoxy-6-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaen-16-one

C28H24N4O7 (528.1645)

(6bs,10r,10as,11s)-10-(3,4-dihydroxyphenyl)-5-hydroxy-11-(4-hydroxy-2-methoxyphenyl)-6-methoxy-8-methyl-6bh,9h,10h,10ah,11h-indeno[2,1-f]chromen-3-one

C31H28O8 (528.1784)

3,4',6-trihydroxy-4-(4-hydroxyphenyl)-5-[(3-phenylpropanoyl)oxy]-[1,1'-biphenyl]-2-yl butanoate

C31H28O8 (528.1784)

4-[(4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl)oxy]-2,5-dihydroxy-9-methoxy-2-methyl-3,4-dihydrotetracene-1,6,11-trione

C27H28O11 (528.1632)

11-(3,4-dihydroxyphenyl)-5-hydroxy-10-(4-hydroxy-2-methoxyphenyl)-6-methoxy-8-methyl-6bh,9h,10h,10ah,11h-indeno[2,1-f]chromen-3-one

C31H28O8 (528.1784)

(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-(2-{[(1s)-1-hydroxy-6-oxocyclohex-2-ene-1-carbonyloxy]methyl}phenoxy)-6-(hydroxymethyl)oxan-3-yl benzoate

C27H28O11 (528.1632)

[2-(acetyloxy)-1-(benzoyloxy)-7-methoxy-2,4a,9,9a-tetrahydro-1h-xanthen-3-yl]methyl benzoate

C31H28O8 (528.1784)

5-(acetyloxy)-2-[4-(acetyloxy)phenyl]-3,6,7-trimethoxy-4-oxochromen-8-yl 2-methylbutanoate

C27H28O11 (528.1632)

[(1s,2s,4as,9as)-2-(acetyloxy)-1-(benzoyloxy)-7-methoxy-2,4a,9,9a-tetrahydro-1h-xanthen-3-yl]methyl benzoate

C31H28O8 (528.1784)

3-acetyl-4a-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-4,6,7-trihydroxy-1-methoxy-12,12a-dihydro-1h-tetracene-2,5-dione

C27H28O11 (528.1632)

3,6,8-trihydroxy-3-methyl-1-oxo-4h-2-benzopyran-4-yl (4e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1h-2-benzofuran-5-yl)-4-methylhex-4-enoate

C27H28O11 (528.1632)

(8e,16r,17s)-16-(3,5-dihydroxyphenyl)-8,17-dimethoxy-9-methyltetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(22),2,4,6,8,10,12,14,18,20-decaene-3,5,13,20-tetrol

C31H28O8 (528.1784)

5-(acetyloxy)-2-[4-(acetyloxy)phenyl]-3,6,7-trimethoxy-4-oxochromen-8-yl (2r)-2-methylbutanoate

C27H28O11 (528.1632)

9-(2h-1,3-benzodioxol-5-yl)-3a,9a-dihydroxy-6,7,8-trimethoxy-1-oxo-3h,4h,9h-naphtho[2,3-c]furan-4-yl 2-methylbut-2-enoate

C27H28O11 (528.1632)

(3r,10ar)-3-chloro-10a-{[(3s,6s)-3-chloro-6-hydroxy-2,2,6-trimethylcyclohexyl]methyl}-4a,6,8-trihydroxy-2,2,7-trimethyl-3h,4h-naphtho[2,3-b]pyran-5,10-dione

C26H34Cl2O7 (528.1681)

(3ar,4r,9r,9as)-9-(2h-1,3-benzodioxol-5-yl)-3a,9a-dihydroxy-6,7,8-trimethoxy-1-oxo-3h,4h,9h-naphtho[2,3-c]furan-4-yl (2z)-2-methylbut-2-enoate

C27H28O11 (528.1632)

4,5-bis(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-10-oxo-9h-anthracen-2-yl)oxy]-6-methyloxan-3-yl acetate

C27H28O11 (528.1632)

5-ethenyl-4-({6-hydroxy-9h-pyrido[3,4-b]indol-1-yl}methyl)-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

C26H28N2O10 (528.1744)

6,14-dihydroxy-15-{[2-hydroxy-6-(3-hydroxy-5-methylphenoxy)-4-methylphenyl]methyl}-4,7,12-trimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one

C31H28O8 (528.1784)

(2r,3s,4r,5s,6r)-3,5-dihydroxy-2-{2-[(1-hydroxy-6-oxocyclohex-2-ene-1-carbonyloxy)methyl]phenoxy}-6-(hydroxymethyl)oxan-4-yl benzoate

C27H28O11 (528.1632)

(2s,4r)-4-{[(2r,3s,4r,5r,6s)-4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl]oxy}-2,5-dihydroxy-9-methoxy-2-methyl-3,4-dihydrotetracene-1,6,11-trione

C27H28O11 (528.1632)

(2s,3r,4r,5s,6s)-4,5-bis(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-10-oxo-9h-anthracen-2-yl)oxy]-6-methyloxan-3-yl acetate

C27H28O11 (528.1632)

10-(3,4-dihydroxyphenyl)-5-hydroxy-11-(4-hydroxy-2-methoxyphenyl)-6-methoxy-8-methyl-6bh,9h,10h,10ah,11h-indeno[2,1-f]chromen-3-one

C31H28O8 (528.1784)

(2r,3r,4r,5r,6s)-2-(acetyloxy)-3,5-dihydroxy-6-[(9r)-4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl]oxan-4-yl 3-methylbut-2-enoate

C27H28O11 (528.1632)

4,5-dihydroxy-2-{2-[(1-hydroxy-6-oxocyclohex-2-ene-1-carbonyloxy)methyl]phenoxy}-6-(hydroxymethyl)oxan-3-yl benzoate

C27H28O11 (528.1632)

(2r,4r,5r,6s)-11,12,18,23-tetrahydroxy-5-methoxy-6-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaen-16-one

(2r,4r,5r,6s)-11,12,18,23-tetrahydroxy-5-methoxy-6-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaen-16-one

C28H24N4O7 (528.1645)

(6bs,10r,10as,11s)-11-(3,4-dihydroxyphenyl)-5-hydroxy-10-(4-hydroxy-2-methoxyphenyl)-6-methoxy-8-methyl-6bh,9h,10h,10ah,11h-indeno[2,1-f]chromen-3-one

C31H28O8 (528.1784)

(1s,4ar,12as)-3-acetyl-4a-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4,6,7-trihydroxy-1-methoxy-12,12a-dihydro-1h-tetracene-2,5-dione

C27H28O11 (528.1632)

2-(acetyloxy)-3,5-dihydroxy-6-(4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl)oxan-4-yl 3-methylbut-2-enoate

C27H28O11 (528.1632)

(6bs,10r,10as,11r)-10-(3,4-dihydroxyphenyl)-5-hydroxy-11-(4-hydroxy-2-methoxyphenyl)-6-methoxy-8-methyl-6bh,9h,10h,10ah,11h-indeno[2,1-f]chromen-3-one

C31H28O8 (528.1784)

3,4,5-tris[(2-phenylacetyl)oxy]cyclohex-1-ene-1-carboxylic acid

C31H28O8 (528.1784)

(4s,5r,6s)-5-ethenyl-4-({6-hydroxy-9h-pyrido[3,4-b]indol-1-yl}methyl)-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

C26H28N2O10 (528.1744)